{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:54:07Z","timestamp":1761155647219},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,12]],"date-time":"2013-01-12T00:00:00Z","timestamp":1357948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s11894-012-0304-2","type":"journal-article","created":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T10:39:54Z","timestamp":1357900794000},"source":"Crossref","is-referenced-by-count":12,"title":["An Update on the Hepatitis E Virus"],"prefix":"10.1007","volume":"15","author":[{"given":"Seth N.","family":"Sclair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene R.","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,12]]},"reference":[{"issue":"1","key":"304_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000149370","volume":"20","author":"MS Balayan","year":"1983","unstructured":"Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 1983;20(1):23\u201331.","journal-title":"Intervirology"},{"issue":"4948","key":"304_CR2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.2107574","volume":"247","author":"GR Reyes","year":"1990","unstructured":"Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 1990;247(4948):1335\u20139.","journal-title":"Science"},{"issue":"11","key":"304_CR3","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1128\/JVI.65.11.5790-5797.1991","volume":"65","author":"PO Yarbough","year":"1991","unstructured":"Yarbough PO, Tam AW, Fry KE, et al. Hepatitis E Virus: identification of type-common epitopes. J Virol. 1991;65(11):5790\u20137.","journal-title":"J Virol"},{"key":"304_CR4","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1053\/j.gastro.2011.07.051","volume":"141","author":"TJ Davern","year":"2011","unstructured":"Davern TJ, Chalsani N, Fontana RJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology. 2011;141:1666\u201372.","journal-title":"Gastroenterology"},{"key":"304_CR5","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1365-2036.2007.03504.x","volume":"26","author":"HR Dalton","year":"2007","unstructured":"Dalton HR, Fellows HJ, Stableforth W, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther. 2007;26:1429\u201335.","journal-title":"Aliment Pharmacol Ther"},{"key":"304_CR6","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(07)60595-9","volume":"369","author":"HR Dalton","year":"2007","unstructured":"Dalton HR, Hazeldine S, Banks M, et al. Locally acquired hepatitis E in chronic liver disease. Lancet. 2007;369:1260.","journal-title":"Lancet"},{"key":"304_CR7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2893.2007.00858.x","volume":"14","author":"JM Peron","year":"2007","unstructured":"Peron JM, Bureau C, Poirson H, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat. 2007;14:298\u2013303.","journal-title":"J Viral Hepat"},{"key":"304_CR8","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM200210313471819","volume":"347","author":"K Suzuki","year":"2002","unstructured":"Suzuki K, Aikawa T, Okamato H. Fulminant Hepatitis E in Japan. N Engl J Med. 2002;347:1456.","journal-title":"N Engl J Med"},{"key":"304_CR9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2169\/internalmedicine.42.1065","volume":"42","author":"H Okamoto","year":"2003","unstructured":"Okamoto H, Takahashi M, Nishizawa T. Features of hepatitis E virus infection in Japan. Intern Med. 2003;42:1065\u201371.","journal-title":"Intern Med"},{"key":"304_CR10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2006.09.016","volume":"46","author":"S Kumar Acharya","year":"2007","unstructured":"Kumar Acharya S, Kumar Sharma P, Singh R, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007;46:387\u201394.","journal-title":"J Hepatol"},{"key":"304_CR11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1440-1746.2004.03188.x","volume":"19","author":"J Ramachandran","year":"2004","unstructured":"Ramachandran J, Eapen CE, Kang G, et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol. 2004;19:134\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"304_CR12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrgastro.2012.121","volume":"9","author":"HR Dalton","year":"2012","unstructured":"Dalton HR. Hepatitis E, and decompensated chronic liver disease. Nat Rev Gastroenterol Hepatol. 2012;9:430\u20132.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"304_CR13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1017\/S0950268809990306","volume":"2","author":"HR Dalton","year":"2010","unstructured":"Dalton HR, Bendall RP, Pritchard C, et al. National mortality rates from chronic liver disease and consumption of alcohol and pig meat. Epidemiol Infect. 2010;2:174\u201382.","journal-title":"Epidemiol Infect"},{"key":"304_CR14","first-page":"173","volume":"31","author":"E Tsega","year":"1993","unstructured":"Tsega E, Krawczynski K, Hansson BG, et al. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J. 1993;31:173\u201381.","journal-title":"Ethiop Med J"},{"key":"304_CR15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jcv.2012.01.016","volume":"54","author":"R Anty","year":"2012","unstructured":"Anty R, Ollier L, Peron JM, et al. First case report of an acute genotype 3 hepatitis E infected pregnant woman living in South France. J Clin Virol. 2012;54:76\u20138.","journal-title":"J Clin Virol"},{"key":"304_CR16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jcv.2010.06.016","volume":"49","author":"S Tavitan","year":"2010","unstructured":"Tavitan S, Peron JM, Huynh A, et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol. 2010;49:141\u20134.","journal-title":"J Clin Virol"},{"key":"304_CR17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/0003-4819-150-6-200903170-00026","volume":"150","author":"L Ollier","year":"2009","unstructured":"Ollier L, Tieulie N, Sanderson F, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med. 2009;150:430\u20131.","journal-title":"Ann Intern Med"},{"key":"304_CR18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","volume":"358","author":"N Kamar","year":"2008","unstructured":"\u2022\u2022 Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic Hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811\u20137. First study that described that HEV infections can become chronic in immunosuppressed patients.","journal-title":"N Engl J Med"},{"key":"304_CR19","doi-asserted-by":"crossref","unstructured":"Gerolami R, Moal V, Colson P, et al. Chronic hepatitis E with cirrhosis in a kidney transplant recipient. N Engl J Med. 2008; 859-60.","DOI":"10.1056\/NEJMc0708687"},{"key":"304_CR20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/TP.0b013e3181c4096c","volume":"89","author":"N Kamar","year":"2010","unstructured":"Kamar N, Abravanel F, Selves J, et al. Influence of immunosuppressive therapy on the natural histrory of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation. 2010;89:353\u201360.","journal-title":"Transplantation"},{"key":"304_CR21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/655899","volume":"202","author":"F Legrand-Abravanel","year":"2010","unstructured":"Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis. 2010;202:835\u201344.","journal-title":"J Infect Dis"},{"key":"304_CR22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/lt.21958","volume":"16","author":"S Pischke","year":"2010","unstructured":"Pischke S, Suneetha PV, Baechlein C, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl. 2010;16:74\u201382.","journal-title":"Liver Transpl"},{"key":"304_CR23","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Kumar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140:1481\u20139. Multicenter observational study of solid organ transplant recipients who contracted hepatitis E infections, including patients who had chronic infections.","DOI":"10.1053\/j.gastro.2011.02.050"},{"key":"304_CR24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJMc0903778","volume":"361","author":"H Dalton","year":"2009","unstructured":"Dalton H, et al. Persistent carriage of hepatitis E virus in patient with HIV infection. N Engl J Med. 2009;361:1025\u20137.","journal-title":"N Engl J Med"},{"key":"304_CR25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3201\/eid1803.111278","volume":"18","author":"NF Crum-Cianflone","year":"2012","unstructured":"Crum-Cianflone NF, Curry J, Drobeniuc J, et al. Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis. 2012;18:502\u20136.","journal-title":"Emerg Infect Dis"},{"key":"304_CR26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jhep.2011.01.009","volume":"54","author":"JM Peron","year":"2011","unstructured":"Peron JM, Dalton H, Izopet J, et al. Acute autochthonous hepatitis E in western patients with underlying chronic disease: a role for ribavirin? J Hepatol. 2011;54:1323\u20135.","journal-title":"J Hepatol"},{"key":"304_CR27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcv.2011.06.004","volume":"52","author":"R Gerolami","year":"2011","unstructured":"Gerolami R, Borentain P, Raissouni F, et al. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol. 2011;52:60\u20132.","journal-title":"J Clin Virol"},{"key":"304_CR28","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfq282","volume":"25","author":"N Kamar","year":"2010","unstructured":"Kamar N, Abravanel F, Garrouste C, et al. Three month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant. 2010;25:2792\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"304_CR29","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2010.08.002","volume":"139","author":"N Kamar","year":"2010","unstructured":"\u2022\u2022 Kamar N, Rostaing L, Abravanel F, et al. Ribavirin inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology. 2010;139:1612\u20138. Pilot study of 6 kidney transplant patients with chronic HEV infection who were treated with ribavirin.","journal-title":"Gastroenterology"},{"key":"304_CR30","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1053\/j.gastro.2012.02.014","volume":"142","author":"H Wedemeyer","year":"2012","unstructured":"Wedemeyer H, Pischke S, Manns MP, et al. Pathogenesis and treatment of hepatitis E virus infection. Gastroenterology. 2012;142:1388\u201397.","journal-title":"Gastroenterology"},{"key":"304_CR31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/lt.21926","volume":"16","author":"EB Haagsma","year":"2010","unstructured":"Haagsma EB, Riezebos-Brilman A, van den Berg AP, et al. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha 2b. Liver Transpl. 2010;16:474\u20137.","journal-title":"Liver Transpl"},{"key":"304_CR32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1086\/650488","volume":"50","author":"N Kamar","year":"2010","unstructured":"Kamar N, Rostaing L, Abravanel F, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis. 2010;50:30\u20133.","journal-title":"Clin Infect Dis"},{"key":"304_CR33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-153-2-201007200-00256","volume":"153","author":"L Alric","year":"2010","unstructured":"Alric L, Bonnet D, Laurent G, et al. Chronic hepatitis E virus infection: successful virologic response to pegylated Interferon- alpha therapy. Ann Intern Med. 2010;153:135\u20136.","journal-title":"Ann Intern Med"},{"key":"304_CR34","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ajg.2011.158","volume":"106","author":"L Alric","year":"2011","unstructured":"Alric L, Bonnet D, Beynes-Rauzy O, et al. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. Am J Gastroenterol. 2011;106:1562\u20133.","journal-title":"Am J Gastroenterol"},{"key":"304_CR35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-153-2-201007200-00257","volume":"153","author":"V Mallet","year":"2010","unstructured":"Mallet V, Nicand E, Sultanik P, et al. Brief communication: case reports of ribavirin treatement for chronic hepatitis E. Ann Intern Med. 2010;153:85\u20139.","journal-title":"Ann Intern Med"},{"key":"304_CR36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.7326\/0003-4819-155-7-201110040-00017","volume":"155","author":"HR Dalton","year":"2011","unstructured":"Dalton HR, Keane FE, Bendall R, et al. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med. 2011;155:479\u201380.","journal-title":"Ann Intern Med"},{"key":"304_CR37","unstructured":"Aggarwal R. HEV vaccine, where are we? Presented at the International Liver Congress 2012. Barcelona, Spain. April 20, 2012."},{"key":"304_CR38","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa061847","volume":"356","author":"MP Shrestha","year":"2007","unstructured":"Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007;356:895\u2013903.","journal-title":"N Engl J Med"},{"key":"304_CR39","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","volume":"376","author":"FC Zhu","year":"2010","unstructured":"\u2022\u2022 Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant HEV vaccine in healthy adults: a large scale, radomised, double-blind, placebo controlled, phase 3 trial. Lancet. 2010;376:895\u2013902. Large phase 3 Chinese study that demonstrated efficacy of the HEV vaccine, which has since been approved for use in China.","journal-title":"Lancet"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-012-0304-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-012-0304-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-012-0304-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T06:09:49Z","timestamp":1595225389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-012-0304-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,12]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["304"],"URL":"https:\/\/doi.org\/10.1007\/s11894-012-0304-2","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,12]]},"article-number":"304"}}